Latest News
Venture capital company Aster has appointed Jérome Joaug as a Principal.
Joaug, co-founder of Nymbly and Cambridge Nanosystems, and a digital transformation specialist, has joined the management company’s investment team, where he will be involved in selecting and supporting the most promising startups in the areas of mobility, energy and industry.
A graduate of the École Polytechnique and the University of Cambridge in 2012, Jérome Joaug co-founded Cambridge Nanosystems, a leader in the environmentally-friendly production of high-quality graphene which was sold in 2016. After this first foray into entrepreneurship at age 24, he was a business angel for several
Emre Akcakmak, Portfolio Adviser at emerging and frontier markets manager East Capital, comments on the implications of Saudi Arabia’s inclusion in the FTSE Russell EM Index…
Saudi Arabia’s inclusion into various emerging markets indices is no surprise to us, as investors who have been witnessing significant efforts by the regulators, especially over the past two years. Next, and perhaps a more important step, will be an EM inclusion by MSCI which is tracked by a larger pool of assets.
With a USD500 billion market capitalisation that is comparable to South Africa, Indonesia, Malaysia and Russia, some 2.5 per cent
Rasmala Group’s Rasmala Trade Finance Fund has crossed the USD250 million threshold in assets under management. The Fund has generated an annualised return of 4.45 per cent since its inception in September 2014.
Rasmala said that heightened demand from asset managers to access genuinely uncorrelated investment products has seen the Fund grow significantly in just the last year. The Fund is proving to be popular among institutional investors and family offices seeking uncorrelated returns.
It added that it expects this trend to continue following the correction in the bond market, as institutions continue to diversify their portfolios beyond equities
Apposite Capital, a private equity firm with an exclusive focus on healthcare, has teamed with management to acquire OrthoD Group from The Riverside Company.
OrthoD is a specialist manufacturer and distributor of medical products and implants for joint reconstruction, sport medicine, surgical products and infection control applications. Financial details have not been disclosed.
Apposite Capital sees significant potential in supporting management in further building OrthoD’s export channels and in further commercialising OrthoD’s sport medicine products. In conjunction with its investment, Apposite has introduced Oern Stuge, MD, as Non-Executive Chairman. Oern brings over 25 years’ experience in the medtech industry
Three Hills Capital Partners (THCP) has made an investment in Sigma Retail Solutions (Sigma), a provider of outsourced solutions to blue chip retailers across the UK, Europe and Australia.
The Company offers a wide range of services from procurement to project delivery and supply chain solutions of various specialist fixtures and fittings.
Sigma was founded in 2007 by Jonathan Haigh and is led by CEO Craig Bennett along with a team of highly experienced divisional directors. The Company is a leading GNFR (Goods Not For Resale) solutions provider, delivering consistently outstanding service and cost savings to its clients.
UgenTec, a medical technology company that has developed an AI-driven polymerase chain reaction (PCR) analysis and workflow software, has closed a USD9.3 million (EUR7.5 million) funding round.
UgenTec automates and standardises high-throughput molecular diagnostics, particularly PCR. PCR analysis is a widely-adopted method for analysing DNA. It has enabled molecular laboratories to test DNA samples for a wide field of applications including infectious disease and oncology.
The company’s software FastFinder reduces workload for lab technicians and improves the reliability of results by introducing reproducible artificial intelligence. PCR analysis is an intensive process that requires considerable time and manual input from
Willkie Farr & Gallagher has appointed Mark Proctor as a partner in the Asset Management Group in the firm’s New York office.
Proctor advises private fund managers on structuring, establishing, and operating private investment funds, including blind pools, co-investment funds, pledge funds, and other investment vehicles. Mr. Proctor also represents fund managers on their internal structuring and compensation matters, and frequently advises clients in connection with co-investments and seed investments in asset managers, as well as buyers and sellers in secondary market transactions involving private fund interests and portfolios of assets held by private funds. Mr. Proctor’s practice extends beyond
SK Capital, a private investment firm focused on the chemicals, specialty materials, and pharmaceuticals sectors, completed its previously announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd (ICL). The businesses have been renamed Perimeter Solutions (Perimeter) and will be headquartered in St Louis, Missouri.
Edward Goldberg, CEO of Perimeter, says: “We are excited to partner with SK Capital, a firm which uniquely understands our business and industry. We look forward to continuing our tradition of being a trusted and reliable partner to our customers and communities we serve, while further investing in Perimeter to accelerate
Pandion Mine Finance, an investment firm backed by MKS PAMP Group and Ospraie Management, that provides flexible financing solutions to developing mining companies, has closed its inaugural fund, Pandion Mine Finance Fund (PMFF) at USD175 million.
Pala Investments Limited committed capital to PMFF.
PMFF seeks to identify attractive investment opportunities with typical investment size ranging from USD10 million to USD40 million. To date, PMFF has committed nearly USD60 million to four junior mining companies: Lupaka Gold Inc; Gowest Gold Ltd; FMS Investimentos e Participações LTDA; and Firesteel Resources Inc.
Ryan Byrne and Joseph Archibald, Co-Founders of Pandion, says,
Midaxo, a Finnish developer of a cloud M&A platform, has closed a EUR12.9m funding round comprising EUR10.3m for the company and EUR2.6m for the existing shareholders – led by major growth investor Idinvest Partners, with the participation of the existing investors Tesi and EOC Capital.
This B round brings Midaxo’s total funding to EUR18.6 million and follows a period of sustained and rapid growth. In 2017, Midaxo more than doubled its revenue and expanded its customer base to hundreds of leading corporations, consultants, and private equity firms, including over 40 companies on the Fortune 1000 list, such as HP, Philips,
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
